A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration
2008 ◽
Vol 56
(5)
◽
pp. 438
◽
2013 ◽
Vol 57
(3)
◽
pp. 283-293
◽
2013 ◽
Vol 127
(3)
◽
pp. 217-225
◽
2010 ◽
Vol 94
(2)
◽
pp. 267-268
◽